| AβOs | Amyloid β oligomers |
| AD | Alzheimer’s disease |
| NDs | Neurodegenerative diseases |
| Aβ | Amyloid beta |
| NFTs | Neurofibrillary tangles |
| PD | Parkinson’s disease |
| MND | Motor neuron diseases |
| HD | Huntington’s disease |
| SCA | Spinocerebellar ataxia |
| SMA | Spinal muscular atrophy |
| pTau | Tau protein |
| CSF | Cerebrospinal fluid |
| PS | Presenilin |
| APP | Amyloid precursor protein |
| FAD | Familial Alzheimer’s disease |
| APOE | Apolipoprotein E |
| PSP | Progressive supranuclear palsy |
| CBD | Corticobasal degeneration |
| FTDP-17 | Frontotemporal dementia and Parkinsonism linked to chromosome 17 |
| LTP | Long-term potentiation |
| LTD | Long-term synaptic depression |
| LMW | Low molecular weight |
| HMW | High molecular weight |
| CNS | Central nervous system |
| NMDAR | N-methyl-d-aspartate receptor |
| ROS | reactive oxygen species |
| CaMKII | Ca2+/calmodulin-dependent kinase II |
| PSD-95 | Postsynaptic density-95 |
| AMPK | AMP-activated kinase |
| GLUTs | Glucose transporters |
| AMPAR | α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor |
| mGluRs | Metabotropic glutamate receptors |
| PrPC | Cellular prion protein |
| AICD | Amyloid intracellular domain |
| BACE1 | β-site APP cleaving enzyme-1 |
| GPI | Glycosylphosphatidylinositol |
| β2ARs | β2-adrenergic receptors |
| α7nAChR | α7 nicotinic acetylcholine receptor |
| IR | Insulin receptor |
| NGF | Nerve growth factor |
| p75NTR | p75 neurotrophin receptor |
| TNF | Tumor necrosis factor |
| IGF-1R | Insulin-like growth factor 1 receptor |
| PI3K | Phosphatidylinositide 3-kinase |
| LilrB2 | Leukocyte immunoglobulin-like receptor B2 |
| LIR | Leukocyte immunoglobulin-like receptors |
| MHC | Major histocompatibility complex |
| PirB | Paired immunoglobulin-like receptor B |
| ODP | Ocular dominance plasticity |
| FcγR | Fc-gamma receptors |
| IgG | Immunoglobulin gamma |
| TREM2 | Triggering receptor expressed on myeloid cells 2 |
| DAP12 | DNAX-activating protein of 12 kDa |
| Eph | Erythropoietin-producing hepatocellular carcinoma |
| FN | Fibronectin |
| RAGE | Receptor for advanced glycation endproducts |
| LRP | Low density lipoprotein-related protein |
| RARβ | Retinoic acid receptor-β |
| HMGB-1 | High mobility group box 1 protein |
| AGE | Advanced glycation endproducts |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| gp330 | Glycoprotein 330 |
| LDLR | Low density lipoprotein receptor |
| NR | Nuclear receptor |
| VDR | Vitamin D receptor |
| LBD | Ligand-binding/dimerization domain |
| DBD | DNA-binding/weak dimerization domain |
| AF-1 | Activation function 1 |
| RXR | Retinoid X receptor |
| SIRT 1 | Sirtuin 1 |